Table 2.

Kaplan-Meier estimates of 1-, 2-, and 3-year continuation of baseline method chosen

	1 Year		2 Year		3 Year
	%	95% CI	%	95% CI	%	95% CI
Overall	76.7	75.4 – 77.9	64.2	62.6 – 65.5	56.2	54.5 – 57.5
LNG-IUD	87.3	85.8 – 88.6	76.7	74.8 – 78.5	69.8	67.6 – 71.7
Cu-IUD	84.5	80.7 – 87.3	76.3	72.1 – 79.8	69.7	65.1 – 73.7
Implant	81.9	78.3 – 84.7	68.7	64.7 – 72.3	56.4	51.8 – 60.3
DMPA	57.4	51.5 – 62.2	40.5	33.8 – 44.7	33.2	26.9 – 37.7
OCP	58.1	56.3 – 64.6	40.1	37.9 – 46.5	29.5	27.3 – 35.8
Ring	53.6	49.7 – 58.6	36.7	33.1 – 41.9	29.1	25.8 – 34.4
Patch	46.1	38.3 – 57.4	35.0	25.7 – 44.5	28.1	19.5 – 37.9
LARC	85.9	84.5 – 87.0	75.2	73.6 – 76.7	67.3	65.4 – 68.9
Non-LARC	55.6	54.2 – 59.4	38.7	36.9 – 42.1	30.2	28.5 – 33.5
Adolescents 14–19 years
LARC	82.1	77.9 – 85.6	68	63.0 – 72.5	52.6	47.2 – 57.7
Non-LARC	46.9	42.1 – 54.6	32.9	28.4 – 40.6	21.2	17.6 – 29.0
Adults 20–45 years
LARC	86.4	85.0 – 87.6	76.2	74.5 – 77.7	69.3	67.4 – 71.0
Non-LARC	57.4	55.7 – 61.3	39.9	37.6 – 43.4	31.9	29.8 – 35.4

^aLNG, levonorgestrel

^bIUD, intrauterine device

^cCu, copper

^dDMPA, depomedroxyprogesterone acetate

^eOral contraceptive pill

^fLARC, long-acting reversible contraceptive

^gCI, confidence Interval